Brian G. Feagan

Statistics

Publications

363

Citations

71.2K

H-Index

116

Active since

1994

Affiliations

Western University(Current)

University of California San Diego

Robarts Clinical Trials

Icahn School of Medicine at Mount Sinai

University of Calgary

Brian G. Feagan is an author at Western University specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and gastrointestinal inflammation.

ORCID

Publications per year

1994–2025

363

Publications

363

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

Veterinary Medicine, Immunology, Pharmacotherapy +12

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn, Brian G. Feagan, Paul Rutgeerts et al. · New England Journal of Medicine · 2013 · 2.7K citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +14

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

Bruce E. Sands, Frank Anderson, Çharles N. Bernstein et al. · New England Journal of Medicine · 2004 · 2.2K citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13

1–5 of 363